Correlation Between Lipocine and 694308KB2
Specify exactly 2 symbols:
By analyzing existing cross correlation between Lipocine and PCG 42 01 MAR 29, you can compare the effects of market volatilities on Lipocine and 694308KB2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of 694308KB2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and 694308KB2.
Diversification Opportunities for Lipocine and 694308KB2
Significant diversification
The 3 months correlation between Lipocine and 694308KB2 is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and PCG 42 01 MAR 29 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PCG 42 01 and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with 694308KB2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PCG 42 01 has no effect on the direction of Lipocine i.e., Lipocine and 694308KB2 go up and down completely randomly.
Pair Corralation between Lipocine and 694308KB2
Given the investment horizon of 90 days Lipocine is expected to generate 1.1 times less return on investment than 694308KB2. In addition to that, Lipocine is 6.57 times more volatile than PCG 42 01 MAR 29. It trades about 0.0 of its total potential returns per unit of risk. PCG 42 01 MAR 29 is currently generating about 0.03 per unit of volatility. If you would invest 9,191 in PCG 42 01 MAR 29 on October 5, 2024 and sell it today you would earn a total of 576.00 from holding PCG 42 01 MAR 29 or generate 6.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 67.44% |
Values | Daily Returns |
Lipocine vs. PCG 42 01 MAR 29
Performance |
Timeline |
Lipocine |
PCG 42 01 |
Lipocine and 694308KB2 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Lipocine and 694308KB2
The main advantage of trading using opposite Lipocine and 694308KB2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, 694308KB2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 694308KB2 will offset losses from the drop in 694308KB2's long position.Lipocine vs. Reviva Pharmaceuticals Holdings | Lipocine vs. ZyVersa Therapeutics | Lipocine vs. Unicycive Therapeutics | Lipocine vs. Checkpoint Therapeutics |
694308KB2 vs. Celsius Holdings | 694308KB2 vs. PepsiCo | 694308KB2 vs. Vodka Brands Corp | 694308KB2 vs. Oatly Group AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |